Calculation of Filing Fee Table
Form S-8
(Form Type)
Silk Road Medical, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| | | | | | | |
| | | | | | | |
Security Type | Security Class Title | Fee Calculation Rule | Amount to be Registered (1) | Proposed Maximum Offering Price Per Share | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee |
Equity | Common Stock, $0.001 par value, reserved for issuance pursuant to 2019 Equity Incentive Plan | 457(c) and 457(h) | 1,399,235 shares (2) | $36.18 (4) | $50,624,322.30 | 0.0000927 | $4,692.88 |
Equity | Common Stock, $0.001 par value, reserved for issuance pursuant to 2019 Employee Stock Purchase Plan | 457(c) and 457(h) | 349,808 shares (3) | $30.76 (5) | $10,760,094.08 | 0.0000927 | $997.46 |
Total Offering Amounts | 1,749,043 shares | | $61,384,416.38 | | $5,690.34 |
Total Fee Offsets (6) | | | | | – |
Net Fee Due | | | | | $5,690.34 |
(1)Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (“Securities Act”), this Registration Statement on Form S-8 (this “Registration Statement”) shall also cover any additional shares of Silk Road Medical, Inc.’s (the “Registrant”) common stock that become issuable under the Registrant’s 2019 Equity Incentive Plan (“2019 Plan”) and the Registrant’s 2019 Employee Stock Purchase Plan (“2019 ESPP”) by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of the Registrant’s outstanding shares of common stock.
(2)Represents an automatic annual increase of 1,399,235 shares on January 1, 2022 to the number of shares of the Registrant’s common stock reserved for issuance under, and which annual increase is provided for in, the 2019 Plan.
(3)Represents an automatic annual increase of 349,808 shares on January 1, 2022 to the number of shares of the Registrant’s common stock reserved for issuance under, and which annual increase is provided for in, the 2019 ESPP.
(4)Estimated in accordance with Rules 457(c) and (h) of the Securities Act solely for the purpose of calculating the registration fee on the basis of $36.18 per share, which represents the average of the high and low prices of the common stock as reported in The Nasdaq Global Select Market on February 28, 2022.
(5)Estimated in accordance with Rules 457(c) and (h) of the Securities Act solely for the purpose of calculating the registration fee on the basis of $30.76 per share, which represents 85% of the average of the high and low prices of the common stock as reported in The Nasdaq Global Select Market on February 28, 2022. Pursuant to the 2019 ESPP, which plan is incorporated by reference herein, the purchase price of the shares of the Registrant’s common stock will be 85% of the lower of the fair market value of the Registrant’s common stock on the first day of the offering period or on the exercise date.
(6) The Registrant does not have any fee offsets.
